• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比利时首次 BNT162b2 疫苗接种活动 6 个月后,接种疫苗的养老院居民和工作人员中 SARS-CoV-2 抗体流行率下降:一项前瞻性队列研究。

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.

机构信息

Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.

Biostatistics Unit, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.

出版信息

Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361.

DOI:10.3390/v14112361
PMID:36366456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9696089/
Abstract

In the SCOPE study, we monitored SARS-CoV-2 antibodies in a national sample of residents and staff from Belgian nursing homes. Here, we report the seroprevalence among infected and infection-naive residents and staff after the primary COVID-19 vaccination campaign. Among 1554 vaccinated nursing home residents and 1082 vaccinated staff from 69 nursing homes in Belgium, we assessed the proportion having SARS-CoV-2 antibodies approximately two (April 2021), four (June 2021), and six months (August 2021) after a two-dose regimen of the BNT162b2 vaccine. We measured the seroprevalence using SARS-CoV-2 antibody rapid tests and collected socio-demographic and COVID-19 medical data using an online questionnaire. Two months after vaccination (baseline), we found a seroprevalence of 91% (95% CI: 89-93) among vaccinated residents and 99% (95% CI: 98-99) among vaccinated staff. Six months after vaccination, the seroprevalence significantly decreased to 68% (95% CI: 64-72) among residents and to 89% (95% CI; 86-91) among staff ( < 0.001). The seroprevalence was more likely to decrease among infection-naive residents, older residents, or residents with a high care dependency level. These findings emphasize the need for close monitoring of nursing home residents, as a substantial part of this population fails to mount a persistent antibody response after BNT162b2 vaccination.

摘要

在 SCOPE 研究中,我们监测了来自比利时养老院居民和工作人员的全国样本中的 SARS-CoV-2 抗体。在这里,我们报告了在 COVID-19 初级疫苗接种运动后感染和无感染居民和工作人员的血清阳性率。在比利时 69 家养老院的 1554 名接种疫苗的养老院居民和 1082 名接种疫苗的工作人员中,我们评估了大约两剂 BNT162b2 疫苗接种后两个月(2021 年 4 月)、四个月(2021 年 6 月)和六个月(2021 年 8 月)时具有 SARS-CoV-2 抗体的比例。我们使用 SARS-CoV-2 抗体快速检测来测量血清阳性率,并使用在线问卷收集社会人口统计学和 COVID-19 医疗数据。接种疫苗两个月后(基线),我们发现接种疫苗的居民血清阳性率为 91%(95%CI:89-93),接种疫苗的工作人员为 99%(95%CI:98-99)。接种疫苗六个月后,居民的血清阳性率显著下降至 68%(95%CI:64-72),工作人员的血清阳性率下降至 89%(95%CI:86-91)(<0.001)。感染无血清阳性率的居民、年龄较大的居民或护理依赖程度较高的居民更有可能降低血清阳性率。这些发现强调了需要密切监测养老院居民,因为很大一部分人群在接种 BNT162b2 疫苗后未能产生持续的抗体反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/9696089/5758760013dd/viruses-14-02361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/9696089/77d1ab5fda71/viruses-14-02361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/9696089/5758760013dd/viruses-14-02361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/9696089/77d1ab5fda71/viruses-14-02361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/9696089/5758760013dd/viruses-14-02361-g002.jpg

相似文献

1
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.比利时首次 BNT162b2 疫苗接种活动 6 个月后,接种疫苗的养老院居民和工作人员中 SARS-CoV-2 抗体流行率下降:一项前瞻性队列研究。
Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361.
2
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.在 COVID-19 疫苗接种运动初期,比利时养老院居民和工作人员中 SARS-CoV-2 抗体的流行情况。
Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28.
3
Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.西弗吉尼亚州养老院队列中 COVID-19 疫苗接种后 SARS-CoV-2 抗体水平的持久性和保护潜力。
JAMA Netw Open. 2022 Sep 1;5(9):e2231334. doi: 10.1001/jamanetworkopen.2022.31334.
4
Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022.2021-2022 年瑞士疗养院接种和未接种疫苗的工作人员和居民中针对 SARS-CoV-2 的中和抗体的长期过程:一项队列研究。
Swiss Med Wkly. 2023 Dec 22;153:3502. doi: 10.57187/s.3502.
5
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.养老院居民中初次接种和加强接种 SARS-CoV-2 信使 RNA 疫苗后的 T 细胞介导的反应。
J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.
6
Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.使用唾液 IgG 评估养老院居民对 SARS-CoV-2 的免疫力。
J Am Geriatr Soc. 2022 Mar;70(3):659-668. doi: 10.1111/jgs.17660. Epub 2022 Jan 22.
7
Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.养老院中初次接触严重急性呼吸综合征冠状病毒2的居民对BioNTech/辉瑞2019冠状病毒病疫苗的抗体反应较差。
Clin Infect Dis. 2022 Aug 24;75(1):e695-e704. doi: 10.1093/cid/ciab998.
8
Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.在养老院居民中,接种 SARS-CoV-2 BNT162b2 mRNA 加强针后抗体明显升高。
Influenza Other Respir Viruses. 2022 Nov;16(6):1066-1071. doi: 10.1111/irv.13030. Epub 2022 Aug 12.
9
Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents.两剂 BNT162b2 疫苗接种后对 SARS-CoV-2 刺突抗体的强烈衰减,以及在疗养院居民中对第三剂的高抗体反应。
J Am Med Dir Assoc. 2022 May;23(5):750-753. doi: 10.1016/j.jamda.2022.02.006. Epub 2022 Feb 23.
10
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.第三剂 COVID-19 mRNA 疫苗缩小了初入养老院居民与健康成年人之间免疫反应的差距。
Vaccine. 2023 Apr 24;41(17):2829-2836. doi: 10.1016/j.vaccine.2023.03.047. Epub 2023 Mar 27.

引用本文的文献

1
Dynamics of SARS-CoV-2 IgG in Nursing Home Residents in Belgium Throughout Three BNT162b2 Vaccination Rounds: 19-Month Follow-Up.比利时养老院居民在三轮BNT162b2疫苗接种期间的新冠病毒IgG动态:19个月随访
Vaccines (Basel). 2025 Apr 15;13(4):409. doi: 10.3390/vaccines13040409.
2
Comparison and Optimization of DNA Extraction Methods for Human DNA from Dried Blood Spot Samples.干血斑样本中人类DNA提取方法的比较与优化
Pediatr Rep. 2025 Mar 4;17(2):30. doi: 10.3390/pediatric17020030.
3
Cycle Threshold Values of SARS-CoV-2 RT-PCR during Outbreaks in Nursing Homes: A Retrospective Cohort Study.

本文引用的文献

1
Humoral and Cellular Responses to COVID-19 Vaccination Indicate the Need for Post-Vaccination Testing in Frail Population.对新冠疫苗接种的体液和细胞免疫反应表明,体弱人群接种疫苗后需要进行检测。
Vaccines (Basel). 2022 Feb 8;10(2):260. doi: 10.3390/vaccines10020260.
2
Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine.第二次接种BNT162b2疫苗后100至200天抗SARS-CoV-2刺突抗体水平的下降
Vaccines (Basel). 2022 Jan 24;10(2):177. doi: 10.3390/vaccines10020177.
3
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
养老院疫情期间新冠病毒逆转录聚合酶链反应的循环阈值:一项回顾性队列研究
Epidemiologia (Basel). 2024 Oct 16;5(4):658-668. doi: 10.3390/epidemiologia5040046.
4
Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination.比利时养老院居民和工作人员在初次接种BNT162b2疫苗后2个月、4个月和6个月时的SARS-CoV-2抗体水平随访
Vaccines (Basel). 2024 Aug 22;12(8):951. doi: 10.3390/vaccines12080951.
5
Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.比利时已完成新冠疫苗基础免疫接种程序的养老院工作人员对新冠疫苗加强针的犹豫态度。
Vaccine X. 2024 Jan 30;16:100453. doi: 10.1016/j.jvacx.2024.100453. eCollection 2024 Jan.
6
No Significant Association between 25-OH Vitamin D Status and SARS-CoV-2 Antibody Response after COVID-19 Vaccination in Nursing Home Residents and Staff.养老院居民和工作人员接种新冠疫苗后,25-羟基维生素D状态与新冠病毒抗体反应之间无显著关联。
Vaccines (Basel). 2023 Aug 8;11(8):1343. doi: 10.3390/vaccines11081343.
7
Validation of a rapid SARS-CoV-2 antibody test in general practice.在全科医学中验证一种快速 SARS-CoV-2 抗体检测方法。
BMJ Open. 2023 May 2;13(5):e069997. doi: 10.1136/bmjopen-2022-069997.
辉瑞-生物科技 COVID-19 mRNA 疫苗(BNT162b2)接种 6 个月后,医护人员和养老院居民体内的疫苗诱导抗体水平和中和活性显著下降。
Clin Infect Dis. 2022 Aug 24;75(1):e884-e887. doi: 10.1093/cid/ciab963.
4
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.辉瑞-BioNTech 信使核糖核酸 COVID-19 疫苗在美国大型综合卫生系统中的 6 个月有效性:一项回顾性队列研究。
Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.
5
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.辉瑞-BioNTech 新冠疫苗接种 6 个月后免疫体液反应逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.
6
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.使用指尖血评估 SARS-CoV-2 暴露风险时,五种快速血清学检测在轻症患者中的表现。
J Clin Virol. 2021 Sep;142:104897. doi: 10.1016/j.jcv.2021.104897. Epub 2021 Jul 16.
7
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.第二次接种BNT162b2或ChAdOx1后刺突抗体水平下降。
Lancet. 2021 Jul 31;398(10298):385-387. doi: 10.1016/S0140-6736(21)01642-1. Epub 2021 Jul 17.
8
Evidence for antibody as a protective correlate for COVID-19 vaccines.针对 COVID-19 疫苗,抗体作为一种保护相关因素的证据。
Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24.
9
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
10
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)-初治疗养院居民中 BNT162b2 信使 RNA 疫苗反应降低。
Clin Infect Dis. 2021 Dec 6;73(11):2112-2115. doi: 10.1093/cid/ciab447.